Insider Trading Alert - CSOD, SNCR, SYK, BEAV And STJ Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Dec. 20, 2013, 106 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $119.02 to $14,400,000,000.00.

Highlighted Stocks Traded by Insiders:

Cornerstone OnDemand (CSOD) - FREE Research Report

Miller Adam L who is President & CEO at Cornerstone OnDemand sold 12,800 shares at $51.53 on Dec. 20, 2013. Following this transaction, the President & CEO owned 3.9 million shares meaning that the stake was reduced by 0.33% with the 12,800-share transaction.

The shares most recently traded at $52.59, up $1.06, or 2.01% since the insider transaction. Historical insider transactions for Cornerstone OnDemand go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 53,800
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 109,000
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 434,888

The average volume for Cornerstone OnDemand has been 501,900 shares per day over the past 30 days. Cornerstone OnDemand has a market cap of $2.7 billion and is part of the technology sector and computer software & services industry. Shares are up 73.72% year-to-date as of the close of trading on Friday.

Cornerstone OnDemand, Inc. provides talent management solutions delivered as software-as-a-service. It offers four integrated clouds for recruiting, learning management, performance management, and extended enterprise. Currently there are 6 analysts that rate Cornerstone OnDemand a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSOD - FREE

TheStreet Quant Ratings rates Cornerstone OnDemand as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and generally high debt management risk. Get the full Cornerstone OnDemand Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Synchronoss Technologies (SNCR) - FREE Research Report

Waldis Stephen G who is CEO and Chairman at Synchronoss Technologies sold 25,000 shares at $29.14 on Dec. 20, 2013. Following this transaction, the CEO and Chairman owned 643,716 shares meaning that the stake was reduced by 3.74% with the 25,000-share transaction.

The shares most recently traded at $30.60, up $1.46, or 4.77% since the insider transaction. Historical insider transactions for Synchronoss Technologies go as follows:

  • 4-Week # shares sold: 26,178
  • 12-Week # shares sold: 95,431
  • 24-Week # shares sold: 236,559

The average volume for Synchronoss Technologies has been 386,100 shares per day over the past 30 days. Synchronoss Technologies has a market cap of $1.2 billion and is part of the technology sector and computer software & services industry. Shares are up 37.55% year-to-date as of the close of trading on Friday.

Synchronoss Technologies, Inc. provides software-based activation and personal cloud solutions for connected devices. The company has a P/E ratio of 103.6. Currently there are 8 analysts that rate Synchronoss Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SNCR - FREE

TheStreet Quant Ratings rates Synchronoss Technologies as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Synchronoss Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Stryker Corporation (SYK) - FREE Research Report

Stryker Ronda E who is Director at Stryker Corporation sold 7,000 shares at $74.09 on Dec. 20, 2013. Following this transaction, the Director owned 11.3 million shares meaning that the stake was reduced by 0.06% with the 7,000-share transaction.

The shares most recently traded at $74.96, up $0.87, or 1.16% since the insider transaction. Historical insider transactions for Stryker Corporation go as follows:

  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 2,000

The average volume for Stryker Corporation has been 1.4 million shares per day over the past 30 days. Stryker Corporation has a market cap of $27.9 billion and is part of the health care sector and health services industry. Shares are up 36.3% year-to-date as of the close of trading on Friday.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. The stock currently has a dividend yield of 1.65%. The company has a P/E ratio of 31.7. Currently there are 14 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYK - FREE

TheStreet Quant Ratings rates Stryker Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Stryker Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

B/E Aerospace (BEAV) - FREE Research Report

Exton Wayne who is Vice President & GM at B/E Aerospace sold 3,000 shares at $84.82 on Dec. 20, 2013. Following this transaction, the Vice President & GM owned 29,864 shares meaning that the stake was reduced by 9.13% with the 3,000-share transaction.

The shares most recently traded at $86.25, up $1.43, or 1.66% since the insider transaction. Historical insider transactions for B/E Aerospace go as follows:

  • 4-Week # shares sold: 66,891
  • 12-Week # shares sold: 66,891
  • 24-Week # shares sold: 73,517

The average volume for B/E Aerospace has been 973,800 shares per day over the past 30 days. B/E Aerospace has a market cap of $8.9 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 73.18% year-to-date as of the close of trading on Friday.

B/E Aerospace, Inc. designs, manufactures, sells, and services cabin interior products for commercial aircraft and business jets worldwide. It operates in three segments: Commercial Aircraft, Consumables Management, and Business Jet. The company has a P/E ratio of 25.2. Currently there are 13 analysts that rate B/E Aerospace a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on BEAV - FREE

TheStreet Quant Ratings rates B/E Aerospace as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full B/E Aerospace Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

St Jude Medical (STJ) - FREE Research Report

Heinmiller John C who is Executive Vice President at St Jude Medical sold 4,144 shares at $59.49 on Dec. 20, 2013. Following this transaction, the Executive Vice President owned 236,357 shares meaning that the stake was reduced by 1.72% with the 4,144-share transaction.

The shares most recently traded at $62.18, up $2.69, or 4.32% since the insider transaction. Historical insider transactions for St Jude Medical go as follows:

  • 4-Week # shares sold: 2,471
  • 12-Week # shares sold: 2,471
  • 24-Week # shares sold: 3,295

The average volume for St Jude Medical has been 2.1 million shares per day over the past 30 days. St Jude Medical has a market cap of $17.7 billion and is part of the health care sector and health services industry. Shares are up 68.29% year-to-date as of the close of trading on Friday.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. The stock currently has a dividend yield of 1.64%. The company has a P/E ratio of 24.6. Currently there are 11 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on STJ - FREE

TheStreet Quant Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full St Jude Medical Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers